Replies to post #102482 on Amfil Technologies Inc (FUNN)

[hotlinktuna]

Super post Rec!! Re-posting:
FY2017 Q1: $28,477
FY2017 Q2: $1,542,389
FY2017 Q3: $1,809,064
FY2017 Q4: $3,251,043
FY2017 Total: $6,630,973

FY2018 Q1: $5,900,374
FY2018 Q2: $3,307,549
FY2018 only 2 quarters in: $9,207,923

All I see is sustained steady growth.

Long AMFE
Rec

BTW, my Twitter name is "longAMFE" ....hehe!!

Cheers!! tuna

[Plowmaster]

That is EXACTLY the correct way to look at it!

AMFE is a sustained growth company.

Audit completion is imminent
Up list right after
Spinoff and Dividend Shares on the heels of uplist
New News on all the development of every single subsidiary:

GRO3
Natural Stuff
Snakes n Lattes
Interloc Kings

Make no mistake, AMFE is an OTC Legend in the making.

AMFE: Undervalued, period!

$$$$ AMFE $$$$

If the post is a bore, set to ignore!

[Zenguy]

Thanks for that chart. Seeing that, how can anyone not get excited for this company's growth and future. looking forward to hearing more soon! Peace!

[Macod]

T12 sales continue to increase which should put a higher floor on the stock.

AMFE quickview quarterly financial comparisons 2017 vs 2018:

Financials

FY2017 Q1: $28,477
FY2017 Q2: $1,542,389
FY2017 Q3: $1,809,064
FY2017 Q4: $3,251,043
FY2017 Total: $6,630,973

FY2018 Q1: $5,900,374
FY2018 Q2: $3,307,549
FY2018 only 2 quarters in: $9,207,923

T12 Sales increased to 14.2M from 12.5M